Collaboration to develop and market vision analysis system

Article

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Pan-European strategic commercial partner Medeuronet will market the system, created by Barcelona-based ophthalmic firm Visiometrics. OQAS is based on the works of Dr Pablo Artal, University of Murcia, Spain.

The system is based on the double-pass technique in which the punctual light source's size and shape projected onto the retina is analysed. The analysis will then provide the user with the point spread function (PSF), tear film quality, optical scattering index (OSI) and the modulation transfer function (MTF) of the eye.

Medeuronet aims to educate users on using the system in a clinical environment and how to make use of its benefits. The OQAS can be used to diagnose pathologies and compare pre and post-cataract and refractive surgery measurements and outcomes.

Other features of the OQAS include accommodation on retinal image quality, objective measurement of halos and glare and presenting the impact of higher-order aberrations and light scatter on visual acuity.

Visiometrics' Chief Executive Officer said, "We see this partnership with Medeuronet as a critical next step in the acceptance of OQAS on a wider commercial scale. We know that OQAS is the key tool to accurately and objectively assess the patient's quality of vision."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.